Fig. 6.
IPD subgroup analyses of vitamin D3 supplementation and cancer-specific survival in the cancer population by age, sex, BMI, ethnicity, vitamin D baseline level, adherence, cancer stage, cancer site, time of cancer diagnosis in all trials (panel A, main analysis) and restricted to trials with a daily dosing regimen (panel B, post-hoc analysis).